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‘free’ inhibin α subunit is expressed 
by bovine ovarian theca cells and its 
knockdown suppresses androgen 
production
Mhairi Laird1, claire Glister1, Warakorn cheewasopit1,2, Leanne S. Satchell1, 
Andrew B. Bicknell1 & phil G. Knight1*
inhibins are ovarian dimeric glycoprotein hormones that suppress pituitary fSH production. they 
are synthesised by follicular granulosa cells as α plus βA/βB subunits (encoded by INHA, INHBA, 
INHBB, respectively). Inhibin concentrations are high in follicular fluid (FF) which is also abundant in 
‘free’ α subunit, presumed to be of granulosal origin, but its role(s) remains obscure. Here, we report 
the unexpected finding that bovine theca cells show abundant INHA expression and ‘free’ inhibin α 
production. Thus, theca cells may contribute significantly to the inhibin α content of ff and peripheral 
blood. In vitro, knockdown of thecal INHA inhibited INSL3 and CYP17A1 expression and androgen 
production while INSL3 knockdown reduced INHA and inhibin α secretion. These findings suggest a 
positive role of thecal inhibin α on androgen production. However, exogenous inhibin α did not raise 
androgen production. We hypothesised that inhibin α may modulate the opposing effects of BMP 
and inhibin on androgen production. However, this was not supported experimentally. furthermore, 
neither circulating nor intrafollicular androgen concentrations differed between control and inhibin 
α-immunized heifers, casting further doubt on thecal inhibin α subunit having a significant role in 
modulating androgen production. Role(s), if any, played by thecal inhibin α remain elusive.
Inhibins are glycoproteins of gonadal origin that play a key role in the negative feedback regulation of FSH pro-
duction by pituitary gonadotrophs. They were first isolated from ovarian follicular fluid in the mid-1980s and 
characterized as disulphide-linked heterodimeric proteins comprising an α subunit linked to one of two β sub-
units (βA or βB) (reviews1–4). The α, βA and βB subunit precursors are encoded by INHA, INHBA and INHBB 
genes, respectively; these are co-expressed primarily in ovarian granulosa cells3,5. Post-translational processing of 
the subunit precursors gives rise to mature inhibin forms (~32 kDa) as well as higher molecular mass (Mr) forms, 
all of which appear to display inhibin-like biological activity (i.e. ability to suppress pituitary FSH secretion)6–8. In 
addition, βA and βB subunits form disulphide-linked homo- (βAβA, βBbB) or hetero-dimers (βAβB) referred to 
as activin A, activin B and activin AB, respectively2,3,5. Like inhibins, activins were also purified from in the mid 
1980s but on the basis of their ability to enhance, rather than suppress, pituitary FSH secretion2,4. Inhibins oppose 
the actions of activins by competing for binding to type 2 activin receptors on the cell surface, an obligatory step 
in activin-induced signalling3,9.
As well as dimeric inhibins and activins, ‘free’ inhibin α subunit has previously been detected in, and isolated 
from, ovarian follicular fluid10–12. Proteolytic processing of full length inhibin α subunit precursor (pro-αNαC; 
MW~50 kDa) generates a series of lower molecular weight peptides including αNαC (MW ~43 kDa), pro-αC 
(~26 kDa) and αN (~23 kDa) but there have been relatively few studies to explore the functional significance 
of ‘free’ α subunit(s) as an intra-ovarian and/or peripheral regulator of cellular function. In contrast to dimeric 
inhibins, inhibin α subunit forms do not suppress the synthesis and secretion of FSH by pituitary gonado-
trophs10,11. Nonetheless, several lines of evidence suggest that inhibin α subunit may have intrinsic biological 
activities distinct from dimeric inhibins and may serve as additional local modulators of follicular function. 
For instance, inhibin α subunit has been shown to inhibit the binding of FSH to granulosal FSH receptors13 and 
to modulate oocyte maturation in a bovine in vitro fertilization/embryo culture model14. Mice with targeted 
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deletions of Inha develop ovarian tumours15 while a spontaneous missense mutation in the human INHA gene is 
associated with premature ovarian insufficiency and primary amenorrhea in women16.
In addition, evidence indicates that free inhibin α subunit may function as an inhibin antagonist (hence 
activin agonist) by competing with inhibin for binding to its co-receptor, betaglycan, to which inhibin binds via 
its α subunit17,18. Association with betaglycan on the cell surface greatly enhances the presentation of inhibin 
to type 2 activin receptors18. By reducing the amount of betaglycan available to bind inhibin, inhibin α subunit 
should compromise the interaction of inhibin with the type 2 activin receptor thereby leaving the receptor more 
freely accessible to activin. Betaglycan is expressed by bovine theca cells and levels increase with follicle develop-
ment19. Inhibin has also been shown to antagonize BMP signalling in several cell-types including human hepat-
ocytes20, mouse adrenocortical cells21, rat gonadotrophs22 and bovine theca cells19, reflecting the requirement for 
BMP interaction with type 2 activin/BMP receptors. It is proposed, therefore, that free inhibin α subunit may also 
function as a local enhancer of BMP signalling at the ovarian level.
Since ovarian granulosa cells are recognised as the principle site of inhibin/activin subunit mRNA expression 
(INHA, INHBA and INHBB) in various mammalian species it has logically been deduced that the high concen-
trations of dimeric inhibin (αβ dimer) and activin (ββ dimer) proteins present in follicular fluid are primarily of 
granulosal origin. Likewise, the high concentrations of free inhibin α subunit identified in follicular fluid were 
presumed to be mainly from granulosa cells10–12. In the present study we report evidence that challenges the latter 
assumption and raises the possibilty that free inhibin α subunit of thecal origin may have a local role to modulate 
follicular androgen production.
Herein, we first report the unexpected finding of high expression levels of INHA mRNA in bovine theca 
interna cells. This finding prompted a follow-on series of experiments to (a) confirm the presence of inhibin 
α subunit protein in theca cells and examine the cellular origin of inhibin α subunit found in bovine follicular 
fluid; (b) determine whether factors shown previously to modulate thecal androgen production (LH, BMPs, EGF, 
TGFα, TNFα) also modulate thecal INHA expression; (c) examine the effects of INHA knockdown and exog-
enous inhibin α subunit treatment on thecal androgen production and (d) test the hypothesis that free inhibin 
α subunit has an autocrine/paracrine role to modulate thecal androgen production by attenuating the effect of 
granulosa-derived inhibin (αβ dimer).
Results
mRnA expression profiles for inHA and inHBA subunits in developing bovine antral folli-
cles. Unexpectedly, appreciable amounts of INHA mRNA were detected in TC with levels similar to those in 
GC found in smaller antral follicles ranging from 1 to 8 mm in diameter (Fig. 1A). The pattern of INHA expression 
in TC was similar to that for CYP17A1 (Fig. 1B) and INHA and CYP17A1 expression levels positively correlated 
across the sample set (r = 0.68; p < 0.0001). Expression of CYP17A1 and INSL3 mRNA (Fig. 1D) was confined 
to TC confirming their status as useful TC markers. The relative abundance of INHBA transcript (Fig. 1C) was 
much greater in GC than in TC (P < 0.0001), particularly in large estrogen-active (LEA) follicles that showed 
greatly increased expression in GC (P < 0.001) compared with GC from all other follicle categories. Likewise, 
INHA mRNA abundance was greatest in GC from LEA follicles (P < 0.01 versus GC from all other follicle cate-
gories), consistent with high output of inhibin A (α-βA dimer) by GC of large antral follicles. Concentrations of 
inhibin α subunit protein measured by ELISA in corresponding bovine follicular fluid samples from these folli-
cles increased ~7-fold between 1–2 and 11–18 mm follicles and followed a similar pattern to those observed for 
INHA and INHBA mRNA expression (Fig. 1E).
Changes in follicular fluid levels of different inhibin α protein forms during antral follicle devel-
opment. Figure 2 shows that the relative amounts of three different molecular mass forms of inhibin α sub-
unit (pro-αNαC, αNαC, pro-αC) in bovine follicular fluid increase in a coordinate manner over the course of 
antral follicle development, being substantially higher in LEA than in large estrogen-inactive (LEI) follicles. This 
pattern was comparable to that observed for ‘total’ inhibin α levels determined by pro-αC ELISA (see Fig. 1E).
theca cells express immunoreactive inhibin α subunit protein. Immunohistochemical staining 
confirmed the presence of inhibin α subunit protein in the theca interna layer of antral follicles (Fig. 3A). Isolated 
TC in primary culture were also immunoreactive for inhibin α subunit (Fig. 3C), and these cells also expressed 
P450c17 (Fig. 3D) and betaglycan protein (Fig. 3E). Immunoblotting analysis of TC-conditioned media (Fig. 4A) 
revealed a prominent band at ~26 kDa under non-reducing conditions and ~20 kDa under reducing conditions. 
This indicated that pro-αC is a major form of inhibin α secreted by TC. Indeed, the pro-αC band intensity was 
much greater than that observed in GC-conditioned media. Higher Mr forms of immunoreactive α subunit 
were also evident, similar to those observed in GC-conditioned media and bovine follicular fluid. Cultured TC 
also secreted detectable amounts of free inhibin α subunit measured using 2-site ELISA employing antibodies 
directed against the pro-region and C-terminal region of the inhibin α subunit presursor (Fig. 4B). Treatment of 
TC with LH did not affect inhibin α secretion.
RNAi-mediated knockdown of INHA and INSL3 reduces thecal expression of INHA mRNA 
and inhibin α subunit protein secretion. Figure 5 shows that in comparison with cells transfected with 
non-silencing control duplex, transfection with an siRNAi duplex targeting INHA reduced INHA mRNA level 
(Fig. 5A) and secreted inhibin α subunit protein level (Fig. 5F) by over 90% (P < 0.01). This was accompanied 
by an 85% reduction in CYP17A1 mRNA level (Fig. 5B; P < 0.001) and androstenedione secretion (Fig. 5G; 
P < 0.01), ~70% reduction in INSL3 mRNA level (Fig. 5C; P < 0.01) whereas INHBA and TGFBR3 (betaglycan) 
mRNA level was not affected (Fig. 5DE). Transfection of cells with an siRNAi duplex targeting INSL3 reduced 
INSL3 mRNA level by over 95% (Fig. 5C) and this was accompanied by an ~80% reduction in INHA mRNA level 
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(Fig. 5A; P < 0.01) and 70% reduction in secreted inhibin α protein level (Fig. 5F; P < 0.05). CYP17A1 mRNA 
level (Fig. 5B; P < 0.001) and androstenedione secretion (Fig. 5G; P < 0.01) were also greatly reduced by INSL3 
knockdown whereas INHBA and TGFBR3 mRNA level was not affected (Fig. 5DE). 
BMps suppress thecal inHA expression and inhibin α secretion. Since BMPs are potent suppressors 
of thecal CYP17A1 expression and androgen secretion, we examined the effects of four different BMPs (BMP 
2, -4, -6, -7) on INHA mRNA expression (Fig. 6A) and inhibin α secretion (Fig. 6B). All four BMPs reduced 
INHA mRNA abundance by over 90% (P < 0.001) while inhibin α secretion was reduced by >80% (P < 0.01). 
Co-treatment with inhibin reversed the suppressive effect of BMP 4, -6 and -7 on thecal INHA expression 
(Fig. 6C). BMP2 was not included in this experiment.
Does exogenous pro-αC modulate basal and LH-induced A4 secretion by theca cells?. Treatment 
of cultured TC with a range of concentrations (200–5000 ng/ml) of highly purified bovine pro-αC isolated from 
bovine follicular fluid had no effect on basal or LH-induced androstenedione secretion (Fig. 7)
can pro-αC antagonise the effect of inhibin on BMP-treated theca cells?. Since inhibin has been 
shown previously to antagonise the suppressive effect of BMP on thecal androgen production19, we predicted that 
exogenous pro-αC would modify this response by impeding inhibin’s action. Cells treated with BMP6 showed 
a marked reduction in androstenedione secretion under both basal and LH-stimulated conditions (Fig. 8). 
Co-treatment with purified bovine inhibin-A significantly attenuated the response to BMP6. However, when 
Figure 1. Changes in relative abundance of mRNA transcripts for (A) INHA, (B) INHBA, C) CYP17A1 
and (D) INSL3 in thecal and granulosal compartments of developing bovine antral follicles. Panel E shows 
corresponding changes in inhibin α subunit concentration of follicular fluid. Follicles in the 11–18 mm size class 
have been subdivided on the basis of oestrogen to progesterone ratio (E:P ratio) as ‘estrogen-active’ (E:P ratio 
>1) or ‘estrogen-inactive’ (E:P ratio <1). Values are means and bars indicate SEM. Results of two-way ANOVA 
are summarized.
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Figure 2. SDS-PAGE/Western blotting analysis (non-reducing conditions) showing changes in the relative 
abundance of three different molecular mass forms of inhibin α subunit protein follicular fluid from bovine 
antral follicles. Follicles in the 11–18 mm size class have been subdivided on the basis of oestrogen to 
progesterone ratio (E:P ratio) as ‘estrogen-active’ (E:P ratio >1) or ‘estrogen-inactive’ (E:P ratio <1). Values are 
means and bars indicate SEM (n = 6–20 per category). Results of two-way ANOVA are summarized.
Figure 3. Immunolocalization of inhibin α subunit in (A) a bovine antral follicle section and (C) cultured 
bovine theca cells. The latter were also shown to be immunoreactive for (D) P450c17 (steroidogenic marker) 
and (E) betaglycan. Antibody controls are shown in panels B, F, G and H. The red bar in A and B = 100 μm; 
yellow bar in H = 20 μm.
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tested at a range of concentrations (0, 200, 1000, 5000 ng/ml) pro-αC did not modulate the ability of inhibin to 
reverse the effect of BMP6 on androgen production.
Do other factors known to modulate thecal steroidogenesis affect INHA expression?. Figure 9 
shows that LH increased androstenedione secretion (p < 0.05) but did not affect INHA expression. Treatment of 
cells with EGF, TGFα and TNFα greatly reduced both androstenedione secretion (p < 0.05) and INHA expression 
(p < 0.05) under both basal and LH-stimulated conditions.
Figure 4. (A) Western blotting analysis of inhibin α subunit immunoreactivity in cultured TC-conditioned 
medium, cultured GC-conditioned medium and pooled bovine follicular fluid, subjected to SDS-PAGE 
under non-reducing (Non-Red) and reducing (Red) conditions. Note the prominent band (~26 kDa, Non-
Red; ~20 kDa, Red) in TC-conditioned medium that corresponds to inhibin pro-αC previously isolated from 
bovine follicular fluid in the authors’ laboratory (Knight et al. 1989). Panel (B) shows that cultured TC secrete 
immunoreactive pro-αC as detected by 2-site ELISA but that LH stimulation (150 pg/ml) does not affect 
secretion.
Figure 5.  Effect of siRNA-mediated knockdown of INHA and INSL3 on expression of (A) INHA, (B) 
CYP17A1, (C) INSL3, (D) INHBA and (E) TGFBR3 mRNA and on secretion of (F) inhibin α subunit protein 
and (G) androstenedione (A4) by bovine TCs in vitro. Control cells were transfected with non-silencing 
control siRNA. Values are means and bars indicate SEM (n = 4 independent cultures). *P     < 0.05, **P < 0.01, 
***P < 0.001 vs. control.
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Are circulating and intrafollicular androgen concentrations perturbed in heifers actively immu-
nized against inhibin α subunit?. To test the hypothesis that in vivo immunoneutralization of inhibin 
α subunit in cattle would perturb ovarian androgen output, plasma and intrafollicular steroids were assayed in 
Figure 6. Suppressive effect of BMP 2, -4, -6, and -7 (10 ng/ml) on (A) expression of INHA mRNA and (B) 
secretion of inhibin α subunit protein by cultured bovine theca cells. The inset (C) shows that co-treatment with 
inhibin-A (50 ng/ml) can partially reverse BMP-induced suppression of thecal INHA expression. Values are 
means and bars indicate SEM (n = 4 independent cultures).
Figure 7. Lack of effect of purified inhibin pro-αC on basal and LH-induced secretion of androstenedione by 
cultured bovine theca cells. Values are means and bars indicate SEM (n = 4 independent cultures).
Figure 8. Co-treatment of cultured theca cells with pro-αC does not modulate the ability of inhibin-A to 
reverse the BMP-induced suppression of thecal androstenedione secretion under either (A) basal or (B) LH-
stimulated conditions. Values are means and bars indicate SEM (n = 4 independent cultures). Within each panel 
means without a common letter are significantly different (p < 0.05).
7Scientific RepoRtS |         (2019) 9:19793  | https://doi.org/10.1038/s41598-019-55829-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
archived samples from a previous study involving active immunization of heifers against inhibin α subunit23. 
These analyses revealed no significant differences in concentrations of androgen (androstenedione/testosterone), 
estradiol or progesterone between control and immunized animals sampled during a prostaglandin-synchronized 
follicular phase (Fig. 10).
Discussion
‘Free’ inhibin α subunit has previously been detected in, and isolated from, ovarian follicular fluid10–12 but its 
functional significance and cellular origin has received relatively little attention. Here, we report that bovine theca 
interna cells express substantial amounts of INHA mRNA that is translated into inhibin α subunit protein, as 
evidenced by immunohistochemistry and western blotting of TC-conditioned culture media. Contrary to expec-
tations, relative INHA mRNA expression levels in thecal and granulosal layers of small to medium size antral 
follicles were found to be similar. Different Mr forms of inhibin α subunit were secreted by cultured TC including 
pro-αC, previously identified in and isolated from bovine FF in this laboratory10. Taken together, these observa-
tions suggest that the theca interna layer may contribute significantly to the inhibin α subunit content of antral 
follicular fluid, hitherto considered to be primarily of granulosal origin4,5,24. Similarly, inhibin α subunit present 
in utero-ovarian vein and jugular vein plasma of cattle10 may be partially of theca origin.
The follicular gene expression profile we observed in GC accords with the consensus view4,25–27 that INHBA 
(encoding inhibin/activin βA subunit precursor) is predominantly expressed by GC of growing follicles with 
maximal expression observed in large oestrogen-active follicles, concomitantly with maximal expression of INHA 
(encoding inhibin α subunit precursor), thus supporting the capacity for high inhibin αβ dimer production by 
GC. Nonetheless, some INHBA expression was also evident in the TC layer of large (11–18 mm) follicles raising 
the possibility that TC in these follicles contribute to the follicular output of inhibin. Indeed, low but detectable 
amounts of inhibin A were detected in TC-conditioned media, with levels 13–30 fold less than in GC-conditioned 
media (see Supplementary Fig. 1). In contrast, activin A levels were undetectable in these TC-conditioned media. 
Moreover, the observation that both follistatin and inhibin A were capable of reversing activin A-induced sup-
pression of thecal androgen secretion, but did not raise androgen production when added alone, further supports 
a lack of endogenous activin production by bovine TC (see Supplementary Fig. 2). Thecal expression of INHBA, 
INHBB and INHA mRNA has also been reported in sheep ovarian follicles28. In the present study, while thecal 
INHA expression level only increased ~2 fold in follicles >9–10 mm in diameter, granulosal expression level 
increased by ~10-fold to peak in LEA follicles. Taken together, the above observations suggest that while GC are 
capable of producing functional dimeric inhibins and activins, ‘free’ inhibin α subunit is mostly produced by the 
follicular TC layer.
This was supported, at least in part, by a western blotting comparison of pooled TC- and GC-conditioned 
culture medium with pooled bovine follicular fluid. This revealed a prominent ~26 kDa band of immunoreactive 
inhibin α subunit in TC-conditioned media that migrated with an apparent Mr of ~20 kDa under reducing con-
ditions. This band corresponds to the inhibin pro-αC form previously isolated from bovine follicular fluid10–12 
and its greater abundance in TC-conditioned medium than in GC-conditioned medium was unexpected. Other 
higher Mr immunoreactive bands were present in all three samples reflecting differential processing of the inhibin 
subunit precursors. The ability of cultured TC to secrete inhibin pro-αC was directly confirmed by 2-site ELISA 
although it should be cautioned that this assay would also be expected to cross react with other molecular forms 
(including α-β dimeric inhibins) that contain both pro- and carboxy-terminal regions of the α subunit precursor. 
Figure 9. Suppressive effect of EGF, TGFα and TNFα, alone, and in combination with LH, on secretion of 
androstenedione and expression of INHA mRNA by bovine TC. Values are means and bars indicate SEM (n = 4 
independent cultures). Means without a common letter are significantly different (P < 0.05).
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Expression of INHA mRNA and inhibin α protein has also been reported in the theca layer of human antral fol-
licles29 but we are not aware of any studies to explore the functional significance of thecal inhibin α in the human 
ovary.
We examined the effects on thecal INHA expression of several factors shown previously to enhance (LH) 
or suppress (BMPs, TNFα, TGFα and EGF) androgen production by cultured TC30–32. Whilst LH, the primary 
endocrine signal promoting thecal androgen production, had no effect on INHA expression, the finding that 
each of the above intra-ovarian growth factors concomitantly suppressed INHA expression and androgen secre-
tion provides further, albeit indirect, evidence that inhibin α subunit may contribute to the regulation of thecal 
steroidogenesis.
Several biological activities have been ascribed to ‘free’ inhibin α subunit including inhibition of FSH binding 
to its receptor13 and inhibition of oocyte maturation14. In addition, immunization of ewes against the αN frag-
ment of the inhibin α subunit precursor was associated with an increased incidence of unruptured ovulatory fol-
licles and reduced fertility33. As discussed below, free inhibin α subunit may also function as an inhibin antagonist 
by competing with inhibin for binding to betaglycan.
Betaglycan acts as a co-receptor for inhibin, to which it binds via its α subunit. This association greatly 
enhances presentation of inhibin to type 2 signaling receptors on the cell surface and facilitates its antagonism of 
activin signalling by preventing formation of signalling complexes between type 2 and type 1 receptors18. In the 
same betaglycan-dependent manner, inhibin can antagonise the effects of BMPs19–21. We reported previously that 
thecal betaglycan mRNA expression increases progressively during bovine antral follicle growth from 1–10 mm, 
preceding the major rise in inhibin α/β subunit expression evident in GC of follicles >9–10 mm in diameter19. 
Figure 10. Lack of effect of active immunization against inhibin α subunit on (A) circulating and (B) intra-
follicular steroid concentrations (means ± SEM) in heifers 1–2 days after prostaglandin-induced luteolysis. 
Androstenedione (A4), testosterone (T4), estradiol (E2) and progesterone (P4).
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This led to the proposal that the ability of GC-derived inhibin to interact with neighbouring TC depends on this 
upregulation of betaglycan expression in growing follicles. In this context, intrafollicular BMPs potently suppress 
LH-induced androgen production30, and this effect is reversed by inhibin19. Thus, enhanced TC androgen output, 
required for the subsequent conversion to oestrogens by GC as follicles progress towards functional dominance 
is likely to depend, at least in part, on increased GC inhibin production. Based on the ability of inhibin to bind 
betaglycan through its α subunit18,20,22, we tested the hypothesis that ‘free’ inhibin α subunit synthesized by theca 
cells might function as an intrafollicular inhibin antagonist (or BMP agonist) by reducing presentation of inhibin 
to type-2 BMP/activin signalling receptors on the theca cell surface. However, we show here that co-treatment 
of theca cells with exogenous inhibin α subunit isolated from bovine follicular fluid did not modify the ability of 
purified bovine inhibin-A to reverse the BMP-induced suppression of androstenedione secretion, casting doubt 
on the validity of this hypothesis. Whilst it is possible that the inhibin α subunit preparation had lost its biological 
activity during the isolation process, this seems unlikely given that the inhibin-A preparation (isolated in parallel 
using the same chromatographic techniques) was biologically active.
Interestingly, BMP-induced suppression of CYP17A1 expression and androgen secretion was accompanied by 
a marked suppression of thecal INHA mRNA expression and inhibin α subunit protein secretion raising the pos-
sibility of a positive role for inhibin α in the maintenance of thecal androgen production. Indeed, such a role was 
supported by our observation that RNAi-mediated knockdown of INHA decreased thecal CYP17A1 expression 
and androgen synthesis. Correspondingly, we anticipated that treating cells with exogenous inhibin α subunit 
would raise androgen production, particularly in BMP6-treated cells with greatly reduced INHA expression. 
However, no effect of inhibin α subunit was found under basal or LH-stimulated conditions (see Fig. 7), or in 
BMP6-treated cells (see Fig. 8) suggesting a more complex (indirect) relationship between BMP signalling, INHA 
expression and androgen biosynthesis. A recent study involving a mouse Leydig cell line (TM3) also showed that 
INHA knockdown decreased expression of cyp17a1 and several other transcripts including Insl334. Moreover, 
TGFβ- and activin-induced Smad2 activation was enhanced by INHA knockdown in TM3 cells. This was inter-
preted as evidence that endogenous inhibins, whose synthesis would be compromised by INHA knockdown, 
counteract the negative effects of TGFβ and activin on TM3 cells.
Notably, INSL3 expression was also greatly reduced by INHA knockdown in TC suggesting a possible asso-
ciation with INSL3-RXFP2 signaling recently shown to contribute, along with BMPs, to the regulation of thecal 
androgen production in the bovine31,35. As mentioned above INHA knockdown also led to a reduction in insl3 
expression in mouse TM3 cells34. Indeed the present finding that BMP 2, 4, 6 and 7 each suppressed INHA expres-
sion and inhibin α protein secretion confirms and extends our previous microarray data showing a substantive 
reduction of thecal INHA expression in BMP6-treated theca cells, with INHA being the third most heavily sup-
pressed transcript in that study31. Conversely, it was also found that knockdown of INSL3 greatly reduced INHA 
mRNA level and inhibin α protein secretion, concomitantly with reduced CYP17A1 expression and androgen 
secretion. This suggests a reciprocal stimulatory action of thecal inhibin α subunit and INSL3 on each other’s 
expression, and on androgen production.
The present findings also raise questions about the mode of action of inhibin αC subunit auto-immunization, 
a vaccination procedure that has been found to enhance ovarian follicle development and raise ovulation rate in 
several species including cattle36,37, sheep38–40 and goat41,42. Previously, it was considered that this action primarily 
involved neutralization of inhibin negative feedback action on pituitary FSH secretion, resulting in raised FSH 
levels that, in turn, enhance follicle development. However, based on the present in vitro findings, we considered 
the possibility that inhibin α antibodies may also directly target follicular theca cells, thereby disrupting intra-
follicular autocrine/paracrine action(s) of theca-derived inhibin α subunit. However, when we examined this 
possibility by analysing intrafollicular and circulating androgen concentrations in heifers actively immunized 
against inhibin α subunit, no significant differences were observed in comparison with non-immunized controls, 
thus casting doubt on this suggestion.
In conclusion, following on from the finding that thecal betaglycan (inhibin co-receptor) and INSL3 expres-
sion increase progressively throughout follicle growth19,35, here we report that TC also express substantial 
amounts of INHA mRNA and ‘free’ inhibin α subunit protein. Moreover, knockdown of thecal INHA suppressed 
CYP17A1 expression and androgen synthesis. Betaglycan and inhibin α have the potential to modulate the action 
of BMPs and inhibin on TC. BMPs concomitantly suppressed INSL3, INHA, CYP17A1 mRNA expression and 
secretion of INSL3, inhibin α subunit and androgen, actions that were reversed by inhibin A. However, no in 
vitro evidence was forthcoming to support the hypothesis that free inhibin α subunit antagonises the effect of 
inhibin on BMP-induced attenuation of thecal androgen production. Furthermore, in vivo immunoneutraliza-
tion of inhibin α did not perturb ovarian androgen production in cattle. In the light of these inconclusive find-
ings, additional studies are needed to define the role(s) of thecal inhibin α subunit and to unravel the specific 
interactions of inhibin, ‘free’ inhibin α subunit, betaglycan, INSL3 and BMPs in the context of ovarian follicle 
steroidogenesis. Figure 11 is a schematic diagram depicting proposed interactions envisioned for BMPs, inhibin, 
BMP-BPs, inhibin α subunit and INSL3 that may contribute to the regulation of CYP17A1 expression and andro-
gen production by theca cells.
Materials and Methods
preparation of granulosal (Gc) and theca interna (tc) extracts for follicular gene expression 
profiling. Antral follicles ranging in diameter from 1 to 18 mm were dissected from ovaries of cattle obtained 
from an abattoir as described previously19. Follicles were sorted by size and their GC, TC layers and follicular 
fluid were recovered. Isolated GC and TC were homogenised in 0.5 ml of Tri-reagent (Sigma UK Ltd) and stored 
at −80 °C prior to RNA extraction. A total of 83 TC samples and 88 GC samples were included in the present 
analysis approximately half of which were generated in the above-mentioned study19. Concentrations of estradi-
ol-17β and progesterone in follicular fluid (n = 99 samples) were determined by immunoassay while total protein 
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concentration was determined by coomassie blue dye-binding assay with bovine serum albumen as the calibra-
tion standard. Follicles in the largest size category (11–18 mm) were subdivided according to their follicular fluid 
estradiol:progesterone (E:P) ratio. Those with an E:P ratio >1 were presumed to be healthy, ‘estrogen-active’ 
dominant follicles, hereafter referred to as large estrogen-active (LEA) follicles. Follicles with an E:P ratio <1 
were presumed to be ‘estrogen inactive’ and regressing and are referred to as large estrogen-inactive (LEI) follicles.
Collection of follicular fluid for western blotting analysis of inhibin α subunit forms. A separate 
set of follicular fluid samples (n = 84) was collected as above for SDS-PAGE/western blotting analysis of different 
molecular weight forms of inhibin α subunit over the course of antral follicle development. Estradiol-17β and 
progesterone concentrations were also measured to allow classification of 11–18 mm follicles into LEA and LEI 
categories on the basis of E:P ratio.
primary theca interna cell culture. TC were isolated from bovine ovaries obtained from the slaughter-
house as described previously30,31. Pooled TC from approximately 50 individual 4–6 mm follicles were seeded 
into either 96-well plates (7.5 × 104 viable cells/well) for evaluation of hormone secretion by immunoassay and 
viable cell number by neutral red uptake assay, or in 24-well plates (0.5 × 106 viable cells/well) for RNA extraction 
and gene expression analysis. Cells were routinely cultured for 6 days under defined serum-free conditions with 
treatments present on days 3–6 inclusive. For RNAi knockdown experiments cells were cultured for 7 days in 
total. The culture medium used was McCoy’s 5 A supplemented with 1% (v/v) antibiotic-antimycotic solution, 
10 ng/ml bovine insulin, 2 mM L-glutamine, 10 mM HEPES, 5 µg/ml apo-transferrin, 5 ng/ml sodium selenite 
and 0.1% (w/v) BSA (all purchased from Sigma UK Ltd, Poole, UK). Antibiotic-antimycotic was omitted from the 
culture medium used during transfection of cells with small interfering (si)RNA duplexes in accordance with the 
protocol provided by the supplier. Media were changed on days 3 and 5 with fresh media containing treatments 
as appropriate. Conditioned media were collected at the end of culture for immunoassay and cell lysates were 
prepared using RNeasy lysis buffer (Qiagen). Pooled lysates from replicate wells were stored at −80C until total 
RNA isolation.
cell culture treatments. Highly purified ovine LH (NIADDK oLH-S-16) was obtained from the 
National Hormone and Pituitary Program (NHPP), Torrance, CA, USA. Recombinant human (rh) BMP2, 
BMP4, BMP6, BMP7, TNFα, TGFα and EGF were purchased from R&D systems (Abingdon, UK). Highly 
purified bovine inhibin A and pro-αC were prepared ‘in house’ from pooled bovine follicular fluid (see 
below). Treatment solutions were sterilized using 0.2 µm membrane filters before dilution in sterile culture 
medium to required concentrations. For experiments involving knockdown of endogenous INHA and INSL3, 
siRNA duplexes against bovine INHA (sense strand: GGGAACUUGUCCUGGCCAAUU; antisense strand: 
UUGGCCAGGACAAGUUCCCUU) and bovine INSL3 (Sense strand: GGCAAGACCUGCUGACCCUUU; 
antisense strand: AGGGUCAGCAGGUCUUGCCUU) were custom-designed and synthesized by Dharmacon 
Thermo Scientific (Lafayette, CO, USA). Controls included cells transfected with a non-silencing control RNAi 
(NSC3; Dharmacon) as well as cells exposed to transfection reagent only (DharmaFECT 2; Dharmacon). All cell 
culture experiments were repeated using TC prepared from n = 4 independent batches of follicles.
Theca cell culture experiments 1–5. Effects of RNAi-mediated knockdown of INHA and INSL3 on 
thecal expression of INHA mRNA and inhibin a subunit protein secretion. To investigate the effect of knock-
down of endogenous INHA and INSL3, TC were transfected with siRNA duplexes (50 nM final concentration), 
non-silencing control duplex (NSC3; Dharmacon; 50 nM) or transfection reagent only (DharmaFECT 2; 0.25 μl/
well). siRNA duplexes were prepared for transfection as recommended in the supplier’s protocol (Dharmacon) 
and added to cells, together with LH (150 pg/ml), after medium changes on days 2 and 4 of culture. Cells were 
lysed 3 days later for RNA extraction and RT-qPCR analysis while media were retained for androstenedione and 
inhibin α subunit assay.
Figure 11. Schematic diagram depicting proposed intrafollicular interactions between BMPs, inhibin, BMP-
binding proteins (BPs), inhibin α subunit and INSL3 that contribute to the regulation of CYP17A1 expression 
and androgen production by theca cells.
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Effect of BMPs on thecal INHA expression and inhibin α secretion. Theca cells cultured in 24-well plates were 
treated for 4 days with BMP2, 4, 6 and 7 (each at 10 ng/ml). In addition, the effects of co-treatment with inhibin 
A (50 ng/ml) on the responses to BMP 4, 6 and 7 were also examined. Expression of INHA mRNA was analysed 
by RT-qPCR and concentrations of inhibin α subunit protein in conditioned media determined by 2-site ELISA.
Does exogenous pro-αC modulate basal and LH-induced androstenedione secretion?. TC cultured in the presence 
and absence of LH (150 pg/ml) were treated for 4 days with highly purified bovine inhibin pro-αC (0, 200, 1000 
and 5000 ng/ml). Media were changed and treatments replenished after 2 days. Concentrations of androstenedi-
one in conditioned media were determined by ELISA.
Does exogenous pro-αC modulate the ability of inhibin to reverse the BMP-induced suppression of thecal andro-
gen secretion?. Since inhibin has been shown previously to antagonise the suppressive effect of BMP on thecal 
androgen production19, we evaluated whether exogenous inhibin pro-αC could modify this response. Under 
both ‘basal’ and LH-stimulated conditions TC were treated with/without BMP6 (10 ng/ml) in the presence and 
absence of purified bovine inhibin-A (500 ng/ml). The above treatment matrix was replicated in cells co-treated 
with purified inhibin pro-αC at three different concentrations (200, 1000, 5000 ng/ml). At the end of culture, 
androstenedione concentrations in conditioned media were determined by ELISA.
Do other factors known to modulate thecal steroidogenesis affect INHA expression?. Since TNFα, TGFα and EGF 
have been shown previously to suppress thecal androgen production31,32, we examined the effects of these pep-
tides (10 ng/ml) on INHA expression by TC cultured in the absence and presence of LH (150 pg/ml).
Are circulating and intrafollicular androgen concentrations perturbed in heifers actively immu-
nized against inhibin α subunit?. To test the hypothesis that in vivo immunoneutralization of inhibin α 
subunit would perturb ovarian androgen output and circulating androgen concentrations, we measured andros-
tenedione, testosterone, estradiol and progesterone concentrations in peripheral plasma samples collected dur-
ing a prostaglandin (PG) synchronized follicular phase from control (n = 8) and inhibin α-immunized (n = 11) 
heifers. Ovaries were recovered after slaughter (day 2 after PG administration) and mean steroid concentrations 
determined in follicular fluid samples pooled from all follicles >5 mm in diameter. These samples had been 
collected during a previous study focussing on the effect of inhibin α immunization on ovulation rate23. The 
study was conducted in full accordance with the UK Animals (Scientific Procedures) Act (1986). Mean inhibin 
α antibody titres (1:2000 plasma dilution) in control and immunized heifers were 0.8 ± 0.06 and 20.7 ± 4.5% 
respectively.
SDS-pAGe and Western Blotting. Before SDS-PAGE, GC- and TC-conditioned cell culture media 
samples were concentrated ~10-fold using centrifugal 10 kDa cut-off membrane filter devices (Amicon Ultra, 
Amicon). Buffer exchange was achieved by loading the filtration devices with non-reducing SDS-PAGE sam-
ple buffer before centrifugation. Follicular fluid samples and concentrated media samples (50 μg protein) were 
electrophoresed under non-reducing and/or reducing conditions using 12.5% gels. After semi-dry transfer to 
nitrocellulose membranes, immunodetection was performed in one of two ways. For semi-quantitative analysis 
of different MW forms of inhibin α in bovine follicular fluid, membranes were incubated overnight with mono-
clonal antibody against inhibin α subunit (clone PPG14; 1 μg/ml; Prof NP Groome, Oxford Brookes University). 
After washing, 125I-labelled goat anti-mouse IgG (105 cpm/ml 3 h incubation at room temperature) was used for 
signal detection and images were captured using a phosphor screen and phosphorimager (Molecular Dynamics) 
with subsequent analysis using Image J 1.3243. For additional experiments comparing cell-conditioned media 
and bovine follicular fluid samples, a biotinylated form of the same primary antibody (PPG14; 0.5 μg/ml) was 
used for immunodetection with signal detection achieved using an ABC peroxidase kit (Vector Laboratories, 
Peterborough, UK) followed by chemiluminescent substrate (ECL reagent, GE Healthcare) and film-based image 
capture.
immunohistochemistry. Immunohistochemistry was performed on formalin-fixed paraffin embedded 
cow ovaries as described previously35. After quenching endogenous peroxidase using hydrogen peroxide, micro-
wave antigen retrieval (10 mM citrate buffer, pH 6) was carried out and sections were blocked using 2.5% (v/v) 
horse serum. Sections were incubated overnight (4 °C) with an ‘in house’ rabbit antibody raised against resi-
dues 1–29 of the αC subunit of bovine inhibin (PPD2/4; 1/2000 dilution). Control sections were incubated with 
normal rabbit serum (1/2000). After washing slides in PBS/Tween the ImmPRESS Universal anti-mouse/rab-
bit IgG HRP polymer-based detection system (Vector Laboratories) was used with diaminobenzidine substrate 
according to the manufacturer’s instructions. Sections were counterstained with haematoxylin, dehydrated and 
mounted. For immunocytochemistry, TC were cultured in NUNC chamber slides and fixed for 30 min in 4% par-
aformaldehyde in PBS (pH 7.4). After permeabilization using 0.1%(v/v) Triton X-100 in PBS (10 min), cells were 
washed in PBS (2 × 5 min) and blocked (1 h) in PBS containing 0.1% NaN3, 2% BSA and 10% normal goat serum. 
After overnight incubation at 4 °C with rabbit anti-inhibin α subunit (PPD2/4; 1/2000), rabbit anti-betaglycan 
(Santa Cruz sc-6199; 5 μg/ml), or rabbit anti-P450 c17 (Gift from Professor S. Kominami, Hiroshima University, 
Hiroshima, Japan; 1:500) or with equivalent concentrations of normal rabbit or mouse IgG as controls, slides 
were washed (3 × 10 min in PBS) and incubated for 1 h with fluor-labelled secondary antibody (10 μg/ml; goat 
anti-rabbit IgG-FITC conjugate). After washing in 0.1% Triton X-100 in PBS for 1 h and then PBS (3 × 10 min) 
slides were mounted in DAPI-contaning medium (Vectashield, Vector Laboratories). Images were captured on a 
Zeiss Axioskop 2 microscope using a Zeiss Axiocam camera with Axiovision software.
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Rt-qpcR. cDNA was synthesized from 1 µg of total RNA using the AB high capacity cDNA reverse transcrip-
tion kit used according to the manufacturer’s instructions (AB, Life Technologies, Paisley, UK). Primers (Table 1) 
were designed using Primer Express software (AB) or Primer-Blast (www.ncbi.nlm.nih.gov/tools/primer-blast/). 
PCR assays were carried out in a volume of 14 µl, comprising 5 µl cDNA (1/50 dilution), 1 µl each forward 
and reverse primers (final concentration 360 nM) and 7 µl SYBR Green 2x Master Mix (QuantiTect; Qiagen, 
UK). Real-time PCR assays were run using an AB StepOne Plus instrument (Life Technologies, Paisley, UK) as 
described elsewhere19. The ΔΔCt method44 was used for comparison of relative transcript abundance. Transcript 
Ct values for each sample were first normalized to ACTB Ct value (which was uniform across all experimental 
groups: ANOVA P > 0.1) to generate ΔCt values. In the case of the follicular GC and TC samples set ΔCt values 
for each transcript in a given sample were then normalized to the mean ΔCt value for that transcript in all tissue 
samples. In the case of cell culture experiments ΔCt values for individual replicates within each treatment group 
were normalized to the mean ΔCt value of vehicle-treated controls. For graphical presentation of results ΔΔCt 
values were finally converted to fold-differences using the formula: fold-difference = 2(−∆∆Ct).
Steroid immunoassays. Steroid concentrations in cell culture media, follicular fluid and plasma samples 
were determined by competitive immunoassays as described previously30,31,35,36. Mean within- and between-assay 
CVs were <8% and <12%, respectively for all analytes.
two-site immunoassay for inhibin pro-αc. Concentrations of inhibin pro-αC in TC-conditioned 
media were determined using a modified version of a previously reported 2-site ELISA45 in which the alkaline 
phosphatase-labelled antibody (anti human αC region) was substituted with a monoclonal antibody (PPG14) 
directed against residues 1–32 of the αC fragment of the bovine inhibin α subunit precursor, to make the assay 
more applicable to the bovine species. In addition, the assay was performed in solid black microplates and a 
fluorogenic substrate (4-methylumbelliferyl phosphate) was used instead of a colorimetric substrate to quantify 
the amount of bound alkaline phosphatase. Fluorescence signals were captured using a multi-function microplate 
reader (Fluostar Optima; BMG Labtech, Aylesbury, Bucks, UK) with excitation and emission wavelengths of 
364 nm and 448 nm, respectively. Highly purified bovine pro-αC purified in this laboratory was used as the assay 
standard. The detection limit was 30 pg/ml and mean intra- and inter-assay CVs were 7% and 10% respectively.
Purification of bovine inhibin A and inhibin pro-αc. Inhibin A and inhibin pro-αC were isolated from 
pooled bovine follicular fluid as described previously14 but with some modifications. Briefly, frozen bovine fol-
licular fluid (65 mg protein/ml) was thawed, centrifuged (20,000 g, 30 min, 4 °C) and the supernatant (150 ml; 
9.75 g protein) subjected to an immunoaffinity extraction step. The immunoaffinity matrix was prepared by cou-
pling 10 mg of a monoclonal antibody raised against bovine αC (clone PPG14) to 5 ml of n-hydroxysuccinamide 
(NHS)-activated sepharose beads (GE Healthcare Ltd), according to the manufacturer’s instructions. Follicular 
fluid was mixed with the immunoaffinity beads overnight at 4 °C using a rotating mixer. The suspension was then 
transferred to an empty column (10 × 80 mm), fitted with a porous polyethylene frit) and the retained beads 
washed by passing through 150 ml PBS followed by a final ‘high salt’ wash (50 ml) of 0.5 M sodium acetate. The 
antibody-bound fraction was then eluted from the beads using 15 ml of 8 M urea solution. After immunoaffinity 
extraction, reversed phase HPLC was used to resolve fractions containing 32 kDa inhibin A and ~26 kDa inhibin 
pro-αC using a TSK-ODS-120T C18 (4.6 × 250 mm) column (Hichrom Ltd, Berks, UK). The column was devel-
oped with a 5 min linear gradient of 10–25% acetonitrile in 0.1% trifluoroacetic acid (TFA), followed by a 40 min 
gradient of 25–75% acetonitrile at a flow rate of 1 ml/min with fraction collected every 0.5 min. Highly enriched 
inhibin A and pro-αC-containing fractions from 12 runs were pooled and each pooled sample was re-applied (2 
runs each) to the same RP-HPLC column that was developed with the same gradient at 1 ml/min; fractions were 
collected every 0.25 min. HPLC column eluates were monitored for UV absorbance at 280 nm and fractions were 
analysed using two-site immunoassay for inhibin A46 and pro-αC (see above). Estimates of total protein concen-
trations and final yields were based on the assumption that a 1 mg/ml solution of protein has a 280 nm absorb-
ance value of 1.0. ELISA revealed that the final pro-αC-containing RP-HPLC preparation contained significant 
(7%) contamination with inhibin A (α-βA dimer). Therefore, an additional immunoaffinity step was employed 
in which the sample was lyophylized, redissolved in PBS and passed through a column containing a 1 ml bed of 
NHS-activated sepharose beads coupled to 1 mg anti-βA mAb (clone E4, Groome). This step effectively depleted 
the inhibin A content of the pro-αC preparation to 0.26%. Table 2 summarized the purification scheme used to 
isolate inhibin A and pro-αC from bovine follicular fluid and the resultant yields.
Target Accession number Forward primer 5′ to 3′ Reverse primer 5′ to 3′
INHBA NM_174363.1 GAAGAGACCCGATGTCACCCAGC TGTCGTCCTCTATCTCCACGTACCCG
INHA NM_174094.3 GAGCCCGAGGACCAAGATGTCTCC CCTCAGCCTCTCCAGCATCTGGC
TGFBR3 XM_001253071.2 TGCACTTTCCTATCCCACAAGCCG CCAGATCATTGAGGCATCCAGCG
CYP17A1 NM_174304 GACAAAGGCACAGACGTTGTGGTCA TGATCTGCAAGACGAGACTGGCATG
INSL3 NM_174365.2 TCTGTCCCCACTGAATCCTCCTGG GGGTTTCATGGTGCTGTGTGGC
ACTB BC102948.1 ATCCACCATCGGCAATGAGCGGTT CGGATGTCGACGTCACACACTTCATG
Table 1. Primers used for real-time PCR.
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Statistical analysis. In vitro hormone secretion data were log-transformed prior to statistical analysis using 
using one- or two-way ANOVA. Where indicated, Fisher’s PLSD test was used for post-hoc pairwise comparisons. 
Values are presented as arithmetic means ± SEM based on 4 independent culture experiments. RT-qPCR data 
from 4 independent batches of cells were analysed (ANOVA and post-hoc Fisher’s PLSD test) as ΔCt values (i.e. 
log2 values) before conversion to fold-difference values for graphical presentation as arithmetic means ± SEM. 
Steroid hormone concentrations in plasma and follicular fluid from control and inhibin-immunized cattle were 
compared by Student’s unpaired t-test.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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